Solid Cash Position and Advancing Clinical Trials Define Compugen’s Q1 2026 Results
Market Chameleon (Mon, 18-May 11:45 AM)
Compugen Extends Cash Runway to 2029 and Turns Profitable with AstraZeneca Deal—What Does This Mean for Investors?
Market Chameleon (Mon, 2-Mar 11:15 AM)
